Keros Therapeutics (KROS) Selling, General & Administrative (2019 - 2026)
Keros Therapeutics (KROS) recorded Selling, General & Administrative of $8.61 million in Q2 2026, down 40.6% from $14.48 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Selling, General & Administrative (2019 - 2026) Analysis & Trends
On a TTM basis, Keros Therapeutics' Selling, General & Administrative came in at $44.96 million as of Jun 30, 2026, down 1.1% year-over-year; for FY2025, it was $46.85 million, up 15.0% from FY2024.
- Annual Selling, General & Administrative has increased for six straight years, with a five-year compound annual growth rate of 29.6% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $40.75 million in FY2024 (+17.0%), $34.83 million in FY2023 (+26.6%), $27.53 million in FY2022 (+29.0%) and $21.33 million in FY2021 (+66.7%).
- The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q1 2023.
- On a year-over-year basis, Selling, General & Administrative rose in six of the last seven quarters, with growth averaging 6.3%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 66.8% in Q4 2021, against a decline of 40.6% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.13 Bn | 1,100.72 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 634.87 Bn | 554.73 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 506.59 Bn | 479.70 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 357.59 Bn | 311.97 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 291.51 Bn | 255.50 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 238.17 Bn | 193.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.18 Bn | 169.37 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Keros Therapeutics | 221.96 Mn | -1.71 Bn | - | 8.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.61 Mn |
| Dec 31, 2025 | 11.74 Mn |
| Sep 30, 2025 | 10.13 Mn |
| Jun 30, 2025 | 14.48 Mn |
| Mar 31, 2025 | 10.50 Mn |
| Dec 31, 2024 | 10.67 Mn |
| Sep 30, 2024 | 9.82 Mn |
| Jun 30, 2024 | 9.96 Mn |
| Mar 31, 2024 | 10.31 Mn |
| Dec 31, 2023 | 9.11 Mn |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 8.80 Mn |
| Mar 31, 2023 | 7.78 Mn |
| Dec 31, 2022 | 7.09 Mn |
| Sep 30, 2022 | 6.94 Mn |
| Jun 30, 2022 | 7.45 Mn |
| Mar 31, 2022 | 6.05 Mn |
| Dec 31, 2021 | 6.03 Mn |
| Sep 30, 2021 | 5.37 Mn |
| Jun 30, 2021 | 5.66 Mn |
API Access
Keros Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();